Xenetic Biosciences, Inc. Closes $15.0 Million Underwritten Public Offering and Completes Acquisition of Innovative CAR T Technology Platform
Stock Information for Xenetic Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.